Trial Profile
The study assessing plasma trough concentrations of antiretrovirals in coinfected persons HIV\HCV treated with direct-acting antiviral agents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Dasabuvir (Primary) ; Dolutegravir (Primary) ; Efavirenz (Primary) ; Etravirine (Primary) ; Lopinavir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Raltegravir (Primary) ; Rilpivirine (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C; HIV infections
- Focus Therapeutic Use
- 16 Nov 2017 New trial record
- 02 Nov 2017 Results published in the Journal of Antimicrobial Chemotherapy.